UGP logo

UGP Total Costs & Expenses

Latest reportedR$39.21B BRL
UGP Quarterly Total Costs & Expenses · BRL (R$382.46M → R$39.21B)
High-resolution chart · PNG

UGP total costs & expenses history

Quarterly · BRL. Dates are reporting period ends; fiscal years can differ from calendar years.

Ultrapar Participacoes S.A. (New) American Depositary Shares (Each representing one Common Share) Total Costs & Expenses — Quarterly (BRL)
Period endingTotal Costs & Expenses (BRL)
39,211,503,755
34,929,064,000
36,820,090,000
35,605,750,000
32,645,187,000
32,346,483,000
33,288,732,000
34,278,411,000
31,481,728,000
29,575,367,000
31,573,460,000
30,916,866,000
29,079,507,000
29,884,362,000
32,620,556,000
38,606,093,000
36,063,626,000
30,951,848,000
30,117,329,000
28,879,096,000
26,048,054,000
21,526,757,000
22,692,811,000
20,158,732,000
15,689,673,000
20,901,101,000
23,703,080,000
22,585,972,000
21,388,972,000
20,320,307,000
22,761,337,000
23,275,226,000
22,211,699,000
20,248,458,000
20,721,767,000
19,577,170,000
18,694,333,000
17,992,762,000
18,303,705,000
18,692,577,000
18,569,889,000
18,743,885,000
19,661,946,000
18,469,475,000
17,912,423,000
16,675,337,000
17,158,798,000
16,734,569,000
16,129,379,000
15,464,508,000
15,614,930,000
15,342,802,000
14,700,028,000
13,181,011,000
13,857,904,000
13,656,982,000
12,636,729,000
12,072,920,000
12,402,087,000
12,511,536,000
11,823,584,000
10,472,098,000
10,854,713,000
10,567,137,000
10,040,014,000
9,679,721,000
10,153,283,000
9,407,386,000
9,406,714,000
6,233,517,000
7,034,734,036
7,683,382,408
6,840,464,442
5,816,000,592
6,241,203,916
6,036,735,917
6,036,282,710
1,112,847,900
1,101,386,157
1,191,199,301
1,113,289,667
1,034,584,012
1,076,555,971
1,153,187,887
1,075,220,370
1,136,860,014
1,073,929,416
1,144,359,304
1,038,185,514
954,468,341
1,013,606,628
950,436,296
834,492,281
850,425,170
895,262,499
667,193,677
579,261,553
504,994,189
519,279,388
514,122,693
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.